Monday, August 21, 2017
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Ventricular Assist Device Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
(March 20, 2017)

LONDON, March 20, 2017 /PRNewswire/ -- North America Ventricular Assist Device Market: Overview

Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts that advance heart failure will become the most common cause of death globally. However, these statistics have already materialized in the U.S. and Canada, where advance heart failure is currently said to be the leading cause of mortality. In Canada, the figures are rising day by day. In Canada nearly 600,000 of the total is affected by heart failure. A large proportion of these population can be saved with proper treatment and care. Thus, the existence of an unmet medical need is clearly evident and is anticipated to augment the ventricular assist device market.

North America Ventricular Assist Device Market: Scope of the Study

This report on the ventricular assist device market in the North America analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2014 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, patent expiry, recent approvals, investment in clinical studies and acquisitions by leading players in the market, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the North America ventricular assist device market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the ventricular assist device market in North America.

North America Ventricular Assist Device Market: Segmentation

Based on product type, the North America ventricular assist device market has been segmented into Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (Bi-VAD) and total artificial heart (TAH).

Based on indication, the North America ventricular assist device market has been segmented into bridge to transplant (BTT), destination therapy (DT) and bridge to recovery (BTR). The American Heart Association reported that 2.6% of the total population is suffering from cardiovascular disease and heart failure is the leading cause of death in the U.S. and around 1.6% in Canada suffer from heart failure, and the number is rising each year. Therefore consequently driving the ventricular assist device market in North America during the forecast period.

North America Ventricular Assist Device Market: Geographical Outlook

Geographically, the North America ventricular assist device market has been segmented into two countries: the U.S. and Canada. These countries have been further segmented by indication and product type. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the ventricular assist device market in North America.

Companies Mentioned in the Report

The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include ABIOMED, St. Jude Medical, HeartWare, SynCardia Systems LLC, Sunshine Heart, Inc., Berlin Heart GmbH

The North America ventricular assist device market has been segmented as follows:

North America Ventricular Assist Device Market, by Product Type

LVAD (Left ventricular assist device)
RVAD (Right ventricular assist device)
Bi-VAD (Biventricular assist device)
TAH( Total artificial heart)

North America Ventricular Assist Device Market, by Indication

BTT (Bridge To Transplant)
DT (Destination Therapy)
BTR (Bridge To Recovery)
Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Email: [email protected]
Tel: +44 208 816 85 48

To view the original version on PR Newswire, visit:

SOURCE ReportBuyer

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:USA, Inc., Medicine, Disease, medical technologists, Surgery, Business,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
  • Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.

  • Gaucher Disease Market Is Anticipated To Witness Growth Owing To Increasing R&D Activities And Special Facility For Orphan Drugs Till 2021 | Million Insights
  • CytRx Corporation Files Preliminary Proxy Statement for Upcoming Special Meeting
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines